This episode currently has no reviews.
Submit ReviewStocks climbing back from an early sell-off, as updates on Trump’s tariff plans filter in. The stocks seeing a comeback, and how the traders are navigating the volatility. And pharma in focus, as the space falls into the red. How fears of rising drug costs are impacting health care, and if the weight loss drug space could see a price surge.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review